Background: Acute myocardial infarction is one of the most frequent causes of admittance and the first cause of death in an intensive care unit from a second-level hospital where the infrastructure, installed capacity and location withheld access to optimal reperfusion treatment.
Objective: To evaluate mortality, length of stay, complications and mechanical ventilation requirement in patients with myocardial infarction who underwent fibrinolysis against those who did not.
Material And Methods: Observational, retrospective and analytic study. Patients admitted to the intensive care unit with ST elevated acute myocardial infarction from October 2008 to September 2018 were included. Reperfusion strategy, time to first attention, cardiovascular and non-cardiovascular complications, as well as outcome were evaluated.
Results: 244 patients were included with mean age of 59.1 ± 10.7 years and high prevalence of obesity, diabetes and hypertension. 183 patients underwent fibrinolysis. Time to treatment was shorter in those thrombolyzed (5.9 ± 5.8 vs. 20.4 ± 11.0 hours; p < 0.0001), with less requirement of mechanical ventilation (26.2 vs. 52.4%; p = 0.002), less intensive care stay (3.0 ± 2.6 vs. 4.6 ± 4.8 days; p = 0.029), less frequency of complications, and significant difference in death (16.3 vs. 50.8%, p < 0.0001).
Conclusions: Fibrinolysis diminished the risk of death, mechanical ventilation requirement, length of stay and cardiovascular and non-cardiovascular complications.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.24875/RMIMSS.M20000031 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Eutectogel-Based Drug Delivery: An Innovative Approach for Atenolol Administration.
Pharmaceutics
December 2024
Dipartimento di Farmacia, Salute e Scienze della Nutrizione, Università della Calabria, Arcavacata di Rende, 87036 Cosenza, Italy.
Hypertension affects 32% of adults worldwide, leading to a significant global consumption of cardiovascular medications. Atenolol, a β-adrenergic receptor blocker, is widely prescribed for cardiovascular diseases such as hypertension, angina pectoris, and myocardial infarction. According to the Biopharmaceutics Classification System (BCS), atenolol belongs to Class III, characterized by high solubility but low permeability.
View Article and Find Full Text PDFAssociation of Metabolic Diseases and Moderate Fat Intake with Myocardial Infarction Risk.
Nutrients
December 2024
Department of Food and Nutrition, Obesity/Diabetes Research Center, Hoseo University, 20 Hoseoro97bungil, BaeBang-Yup, Asan 31499, Republic of Korea.
Background: Myocardial infarction (MI) can range from mild to severe cardiovascular events and typically develops through complex interactions between genetic and lifestyle factors.
Objectives: We aimed to understand the genetic predisposition associated with MI through genetic correlation, colocalization analysis, and cells' gene expression values to develop more effective prevention and treatment strategies to reduce its burden.
Methods: A polygenic risk score (PRS) was employed to estimate the genetic risk for MI and to analyze the dietary interactions with PRS that affect MI risk in adults over 45 years ( = 58,701).
Wnt Signaling Inhibitors as Therapeutic Approach in Ischemic Heart Disease.
Molecules
December 2024
Centre of Experimental Medicine, Slovak Academy of Sciences, 841 04 Bratislava, Slovakia.
Wnt (wingless-type MMTV integration site family) signaling is an evolutionary conserved system highly active during embryogenesis, but in adult hearts has low activities under normal conditions. It is essential for a variety of physiological processes including stem cell regeneration, proliferation, migration, cell polarity, and morphogenesis, thereby ensuring homeostasis and regeneration of cardiac tissue. Its dysregulation and excessive activation during pathological conditions leads to morphological and functional changes in the heart resulting in impaired myocardial regeneration under pathological conditions such as myocardial infarction, heart failure, and coronary artery disease.
View Article and Find Full Text PDFAngiopoietin-2: A Therapeutic Target for Vascular Protection in Hutchinson-Gilford Progeria Syndrome.
Int J Mol Sci
December 2024
Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742, USA.
Hutchinson-Gilford progeria syndrome (HGPS) is a pediatric condition characterized by clinical features that resemble accelerated aging. The abnormal accumulation of a toxic form of the lamin A protein known as progerin disrupts cellular functions, leading to various complications, including growth retardation, loss of subcutaneous fat, abnormal skin, alopecia, osteoporosis, and progressive joint contractures. Death primarily occurs as the result of complications from progressive atherosclerosis, especially from cardiac disease, such as myocardial infarction or heart failure, or cerebrovascular disease like stroke.
View Article and Find Full Text PDFMechanisms and Therapeutic Potential of Multiple Forms of Cell Death in Myocardial Ischemia-Reperfusion Injury.
Int J Mol Sci
December 2024
Centre for Heart Research, The Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW 2145, Australia.
Programmed cell death, especially programmed necrosis such as necroptosis, ferroptosis, and pyroptosis, has attracted significant attention recently. Traditionally, necrosis was thought to occur accidentally without signaling pathways, but recent discoveries have revealed that molecular pathways regulate certain forms of necrosis, similar to apoptosis. Accumulating evidence indicates that programmed necrosis is involved in the development of various diseases, including myocardial ischemia-reperfusion injury (MIRI).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!